Business

The Oregon Health Authority said the deal is not likely to greatly reduce access to affordable care in the state, but it placed some conditions on its approval.

Adam Wolfberg, chief medical officer at Current Health, explains how the company fits into Best Buy Health's strategy and where the focus lies in the new year.

Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment.

Although investment slowed for startups, leaders noted several big deals in digital health, particularly among retail players.

Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.

Execs said investors will focus on companies with evidence of market fit, established business models and those achieving measurable health outcomes.   

The year was plagued by layoffs, slowing investments and an increased need for companies to prove their market value.

The U.S. International Trade Commission determined Apple Watches with ECG functionality violate AliveCor patents, but an import ban is on hold until appeals wrap up in a case before the U.S. Patent and Trademark Office's Patent Trial and Appeal Board.

DailyEndorphin's corporate team challenges will be added to Wellable's Wellness Platform.

Aegis Ventures' John Beadle discusses partnerships between venture capital firms and health systems, the move from direct-to-consumer to business-to-business models and what digital health investment could look like next year.